Literature DB >> 6319756

Polyomavirus growth and persistence in Friend erythroleukemic cells.

P Delli Bovi, V De Simone, R Giordano, P Amati.   

Abstract

Infection of Friend erythroleukemic (FL) cells by polyomavirus (Py) invariably results in the selection of persistently infected FL-Py cell lines and clones. Anti-Py serum treatment of FL-Py lines and clones leads to the loss of Py genome and consequent cell cure. Conversely, cure has not been obtained in FL-PytsA cell lines (isolated after infection by a Py thermosensitive early mutant) and their derivative clones cultivated for a long time at nonpermissive temperature (39 degrees C), where viral large-T protein is inactive. Rescue of viral particles has always been obtained after shifting cells to 32 degrees C. Integrated viral genomes were detected by blot hybridization in an FL-PytsA clone at 39 degrees C. Long-term observation of FL-Py cell lines and their derivative clones reveals a reciprocal selection mechanism (coevolution) between the viral and the cellular populations, resulting in either a completely virus-free Py-resistant FL cell line (cure) or in a continuously Py-shedding line bearing Py genome variants. Structural analysis of these viral populations has been carried out, and some viral variants have been isolated and characterized. On the basis of the results obtained, the possible mechanisms of Py persistence in FL cells will be discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319756      PMCID: PMC255498     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Degradation of cellular mRNA during infection by herpes simplex virus.

Authors:  Y Nishioka; S Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

3.  [Susceptibility of teratocarcinoma cells to simian virus 40 and polyoma virus (author's transl)].

Authors:  M Boccara; F Kelly
Journal:  Ann Microbiol (Paris)       Date:  1978 Feb-Mar

4.  Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells.

Authors:  F K Fujimura; P L Deininger; T Friedmann; E Linney
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

5.  Expression of polyoma early functions in mouse embryonal carcinoma cells depends on sequence rearrangements in the beginning of the late region.

Authors:  M Katinka; M Yaniv; M Vasseur; D Blangy
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

6.  Cloning human fetal gamma globin and mouse alpha-type globin DNA: preparation and screening of shotgun collections.

Authors:  F R Blattner; A E Blechl; K Denniston-Thompson; H E Faber; J E Richards; J L Slightom; P W Tucker; O Smithies
Journal:  Science       Date:  1978-12-22       Impact factor: 47.728

7.  Isolation and characterization of polyoma virus mutants able to develop in embryonal carcinoma cells.

Authors:  M Vasseur; C Kress; N Montreau; D Blangy
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

8.  Trans-complementable copy-number mutants of plasmid ColE1.

Authors:  A J Twigg; D Sherratt
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

9.  Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells.

Authors:  M Katinka; M Vasseur; N Montreau; M Yaniv; D Blangy
Journal:  Nature       Date:  1981-04-23       Impact factor: 49.962

10.  Isolation and characterization of polyoma virus mutants which grow in murine embryonal carcinoma and trophoblast cells.

Authors:  K Tanaka; K Chowdhury; K S Chang; M Israel; Y Ito
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  10 in total

1.  Biological activities of oligonucleotides spanning the F9 point mutation within the enhancer region of polyomavirus DNA.

Authors:  M Satake; K Furukawa; Y Ito
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 2.  Relationship of eukaryotic DNA replication to committed gene expression: general theory for gene control.

Authors:  L P Villarreal
Journal:  Microbiol Rev       Date:  1991-09

3.  Nuclear activity from F9 embryonal carcinoma cells binding specifically to the enhancers of wild-type polyoma virus and PyEC mutant DNAs.

Authors:  F K Fujimura
Journal:  Nucleic Acids Res       Date:  1986-04-11       Impact factor: 16.971

4.  Replicative cis-advantage of polyomavirus regulatory region mutants in different murine cell lines.

Authors:  V De Simone; P Amati
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

5.  Point mutation in the polyomavirus enhancer alters local DNA conformation.

Authors:  F K Fujimura
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

6.  Polyomavirus mutation that confers a cell-specific cis advantage for viral DNA replication.

Authors:  V De Simone; G La Mantia; L Lania; P Amati
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

7.  Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice.

Authors:  R Rochford; B A Campbell; L P Villarreal
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  Viral genomes maintained extrachromosomally in hamster polyomavirus-induced lymphomas display a cell-specific replication in vitro.

Authors:  C de La Roche Saint André; S Mazur; J Feunteun
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  E1A represses wild-type and F9-selected polyomavirus DNA replication by a mechanism not requiring depression of large tumor antigen transcription.

Authors:  N J DePolo; L P Villarreal
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

10.  Selection of mouse neuroblastoma cell-specific polyoma virus mutants with stage differentiative advantages of replication.

Authors:  R Maione; C Passananti; V De Simone; P Delli-Bovi; G Augusti-Tocco; P Amati
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.